Bill Title: Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Sponsorship: Slight Partisan Bill (Democrat 6-2)

Status: (Introduced - Dead) 2016-10-20 - Substituted by S2024 [A3793 Detail]

Text: Latest bill text (Introduced) [HTML]

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
Assembly	Assembly Health and Senior Services Committee: Reported Favorably	2016-10-06	11	0	2	0	13	Passed	Link	View